Skip to main content
FinSpry Logo
FinSpry
STOK logo
STOK
(NASDAQ)
Stoke Therapeutics, Inc.
$32.74-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Stoke Therapeutics (STOK) Stock Price & Financial Analysis

Stoke Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$30.66 - $32.95
52-Week High$40.22
52-Week Low$5.35
Open$31.04
Volume564.30K
Average Volume (3M)564.30K
Market Cap1.92B
Shares Outstanding58.61M
P/E Ratio (TTM)46.22
Price to Sales (P/S)9.12
Price to Book (P/B)6.09
EV/EBITDA61.69
Revenue (TTM)205.63M
Net Income (TTM)40.57M
Free Cash Flow (TTM)52.37M
EPS (TTM)$0.69
Profit Margin19.73%
Operating Margin13.23%
Return on Equity (ROE)13.17%
Debt to Equity0.01
50-Day MA$33.09
200-Day MA$25.85
52-Week Change413.48%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Stoke Therapeutics

What is the current stock price for STOK?

As of the latest trading session, STOK stock trades at $32.74. The 52-week range is $5.35–$40.22, with a day range of $30.66–$32.95.

What is the P/E ratio for STOK?

Stoke Therapeutics's trailing P/E ratio is 46.2, meaning investors pay $46.2 for every $1 of annual earnings. Stoke Therapeutics operates in the Healthcare sector.

Does STOK pay dividends?

Stoke Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for STOK?

Based on 6 analysts, the consensus for STOK is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of STOK?

Stoke Therapeutics's market capitalization is $1.92B, classifying it as a small-cap company. Stoke Therapeutics operates in the Healthcare sector within the Biotechnology industry.